Not checkedNot checked for notices yet.
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
Oscar Fabian Garcia-Aponte, Christoph Herwig, Bence Kozma
Journal of Biological Engineering · 2021
doi:10.1186/s13036-021-00264-7 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing process that is able to control cell growth and functionality towards therapy affordability and opportunity. In this review, we discuss and compare current bioreactor technologies by performing a systematic analysis of the published data on automated lymphocyte expansion for adoptive cell therapy. We propose a set of requirements for bioreactor design and identify trends on the applicability of these technologies, highlighting the specific challenges and major advancements for each one of the current approaches of expansion along with the opportunities that lie in process intensification. We conclude on the necessity to develop targeted solutions specially tailored for the specific stimulation, supplementation and micro-environmental needs of lymphocytes’ cultures, and the benefit of applying knowledge-based tools for process control and predictability.
Abstract licence: CC BY-NC-ND
References209
- 21.
39 more references, whose wording the paper’s licence keeps private.
All 209 referencesCited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.